Výsledky vyhledávání - "S J, Ermlich"

Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects

Autor: M R, Goldberg, Y, Lee, K P, Vyas, D E, Slaughter, D, Panebianco, S J, Ermlich, C R, Shadle, M J, Brucker, D A, McLoughlin, T V, Olah

Publikováno v: Journal of clinical pharmacology. 40(1)

Rizatriptan is a novel 5-HT1D/1B agonist for relief of migraine headache. The pharmacokinetics, metabolite profiles, and tolerability of rizatriptan were examined in a multiple-dose study in healthy subjects. Rizatriptan (N = 24) (or placebo, N = 12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::711b8dbfae5e28481747f5d103496618
https://pubmed.ncbi.nlm.nih.gov/10631625

Zobrazit plný text záznamu

Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females

Autor: Y, Lee, S J, Ermlich, A T, Sterrett, M R, Goldberg, R A, Blum, M J, Brucker, D A, McLoughlin, T V, Olah, J, Zhao, J D, Rogers

Publikováno v: Biopharmaceuticsdrug disposition. 19(9)

The pharmacokinetics and tolerability of intravenous (i.v.) rizatriptan (MK-0462), a novel 5-HT1D/1B receptor agonist for the acute oral treatment of migraine, were examined in an open, single-dose, four-period, randomized crossover study in healthy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::953d31cbe46990aff096daa02ab1f4dc
https://pubmed.ncbi.nlm.nih.gov/9872339

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání